While doctors are reporting positive results, they also told Steinberg that the frequency of side effects such as fingers and toes turning white or blue due to blood circulation problems is also higher than what was reported in clinical trials. Side effects associated with Amgen’s drug include constipation and stomach pain. In such cases, physicians switched patients to either the Teva or Lilly drug.
Amgen migraine drug has worst profile!
- Thread starter anonymous
- Start date
-
- Tags
- None
My personal neurologist states that the other 2 drugs have much better safety profile and are much more tolerable for the patient. They don't see the side-effects with the other drugs that the see with this one.
AMGEN R&D FUCKED!! FUCKED UP!!!! GAVE THE SALES FORCE A DUD!!!!!
FUCK YOU LAZY TO RESEARCHERS!!!! AMGEN DRUG IS SHIT!!!
https://xconomy.com/national/2019/0...aine-drug-competitors-to-make-oral-arguments/
https://www.neurologyadvisor.com/co...anezumab-in-chronic-migraine-with-depression/
Fremanezumab Beneficial in Patients With Chronic Migraine and Moderate to Severe Depression
https://www.cardiovascularbusiness....ar/migraine-drug-might-double-cardioprotector
Migraine drug might double as cardioprotector
The migraine medication galcanezumab might protect against adverse CV events in patients taking the drug for episodic headaches, according to research presented at the American Academy of Neurology’s 2019 meeting in Philadelphia.
In research led by Tina Oakes and supported by Eli Lilly and Company, scientists examined data from two six-month migraine studies and one three-month chronic migraine study in an effort to assess the effect of galcanezumab on heart health. Galcanezumab, sold under the brand name Emgality, is a monoclonal antibody that binds to calcitonin gene-related peptide (CGRP), a microvascular vasodilator that could have a protective role in CV wellness.
FUCK YOU LAZY TO RESEARCHERS!!!! AMGEN DRUG IS SHIT!!!
https://xconomy.com/national/2019/0...aine-drug-competitors-to-make-oral-arguments/
https://www.neurologyadvisor.com/co...anezumab-in-chronic-migraine-with-depression/
Fremanezumab Beneficial in Patients With Chronic Migraine and Moderate to Severe Depression
https://www.cardiovascularbusiness....ar/migraine-drug-might-double-cardioprotector
Migraine drug might double as cardioprotector
The migraine medication galcanezumab might protect against adverse CV events in patients taking the drug for episodic headaches, according to research presented at the American Academy of Neurology’s 2019 meeting in Philadelphia.
In research led by Tina Oakes and supported by Eli Lilly and Company, scientists examined data from two six-month migraine studies and one three-month chronic migraine study in an effort to assess the effect of galcanezumab on heart health. Galcanezumab, sold under the brand name Emgality, is a monoclonal antibody that binds to calcitonin gene-related peptide (CGRP), a microvascular vasodilator that could have a protective role in CV wellness.
